Literature DB >> 19841881

Regulation of p27(kip1) mRNA expression by microRNAs.

Aida Martínez-Sánchez1, Fátima Gebauer.   

Abstract

p27(kip1) (p27) is a cell cycle inhibitor and tumor suppressor whose expression is highly regulated in the cell. Low levels of p27 have been associated with poor prognosis in cancer. Recently, several microRNAs have been described to control p27 expression in various tumor types. In this chapter, we will provide an overview on the role of microRNAs in cancer, and will discuss how microRNAs regulate p27 expression and the implications for tumor progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19841881     DOI: 10.1007/978-3-642-03103-8_4

Source DB:  PubMed          Journal:  Prog Mol Subcell Biol        ISSN: 0079-6484


  4 in total

1.  Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations.

Authors:  Anne Catharina Dressler; Gernot Hudelist; Anneliese Fink-Retter; Daphne Gschwantler-Kaulich; Georg Pfeiler; Margit Rosner; Markus Hengstschläger; Christian F Singer
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-21       Impact factor: 4.553

2.  NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation.

Authors:  Hao Tang; Xiuqin Fan; Junyue Xing; Zhenyun Liu; Bin Jiang; Yali Dou; Myriam Gorospe; Wengong Wang
Journal:  Aging (Albany NY)       Date:  2015-12       Impact factor: 5.682

Review 3.  An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs.

Authors:  Debora Bencivenga; Emanuela Stampone; Angela Vastante; Myassar Barahmeh; Fulvio Della Ragione; Adriana Borriello
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

4.  Partial hepatectomy in rats results in immediate down-regulation of p27Kip1 in residual liver tissue by transcriptional and post-translational processes.

Authors:  Anne-Katrin Rohlfing; Karoline Trescher; Juliane Hähnel; Christian Müller; Jan-Peter Hildebrandt
Journal:  Front Physiol       Date:  2013-06-13       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.